Europe — EMA
Moxonidin Teva (Moxonidine)
GNH USA supplies Moxonidine Teva (Moxonidine), a imidazoline receptor agonist for hypertension. Available in EU markets. Request a quote for global supply.
Request sourcing
What is Moxonidine?
Moxonidine, the active ingredient in Moxonidine Teva, is an imidazoline receptor agonist presented as an oral tablet for oral administration. It selectively reduces sympathetic nervous system activity and is indicated for the management of hypertension in adult patients.
GNH USA supplies Moxonidine Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing products that meet EU regulatory standards and ensuring consistent quality and reliable delivery across global markets.
What is Moxonidine used for?
Moxonidine is used to lower elevated blood pressure by acting on central imidazoline receptors in the management of hypertension.
Hypertension: reduces systolic and diastolic blood pressure in patients with primary hypertension.
What are the side effects of Moxonidine?
Moxonidine may be associated with a range of adverse reactions, which are categorized by frequency.
Common Side Effects: - Dry mouth - Fatigue - Dizziness - Headache - Nausea - Constipation
Serious or Rare Side Effects: - Severe hypotension - Bradycardia - Allergic skin reactions (rash, urticaria) - Liver enzyme elevation - Cardiac arrhythmias - Syncope
What precautions apply to Moxonidine?
When prescribing or dispensing Moxonidine, several safety considerations should be observed.
Blood pressure monitoring: regularly assess to ensure therapeutic response and avoid excessive hypotension. Renal function assessment: adjust dose in patients with moderate to severe renal impairment. Elderly patients: start with lower dose and monitor for dizziness or falls. Concomitant antihypertensives: evaluate for additive blood pressure lowering effects. Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. Store at ambient temperature below 25°C: keep in original packaging, protect from moisture and light.
What does Moxonidine interact with?
Moxonidine can interact with other medicines, requiring attention to avoid adverse outcomes.
Major Interactions (Avoid): - Other central antihypertensives (e.g., clonidine, methyldopa): may cause profound hypotension. - Strong CYP2D6 inhibitors: could increase plasma levels of moxonidine.
Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may attenuate antihypertensive effect. - Diuretics: combined use may enhance hypotensive response. - Beta‑blockers: additive blood pressure lowering may require dose adjustment. - Alcohol: can increase dizziness and risk of hypotension.
